Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             34 results found
no title author magazine year volume issue page(s) type
1 A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice Lesinski, Gregory B
 2001
 19 13-14 p. 1717-1726
10 p.
 article
2 Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia Hartkamp, A
 2001
 19 13-14 p. 1671-1677
7 p.
 article
3 Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination Shu, Pei-Yun
 2001
 19 13-14 p. 1753-1763
11 p.
 article
4 Current status and future trends in vaccine regulation — USA Falk, Lydia A.
 2001
 19 13-14 p. 1567-1572
6 p.
 article
5 Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120 Gorse, Geoffrey J.
 2001
 19 13-14 p. 1806-1819
14 p.
 article
6 Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine Guy, Bruno
 2001
 19 13-14 p. 1794-1805
12 p.
 article
7 Detoxification of endotoxin by aluminum hydroxide adjuvant Shi, Yi
 2001
 19 13-14 p. 1747-1752
6 p.
 article
8 Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation Creusot, Rémi J.
 2001
 19 13-14 p. 1678-1687
10 p.
 article
9 Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain Hagiwara, Yukari
 2001
 19 13-14 p. 1652-1660
9 p.
 article
10 Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse Bachy, Monique
 2001
 19 13-14 p. 1688-1693
6 p.
 article
11 Ensuring vaccine safety in immunization programmes — a WHO perspective Jodar, L
 2001
 19 13-14 p. 1594-1605
12 p.
 article
12 Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals Peeters, Ben P.H.
 2001
 19 13-14 p. 1616-1627
12 p.
 article
13 Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines Lambot, M
 2001
 19 13-14 p. 1827-1835
9 p.
 article
14 Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters Fragaki, Konstantina
 2001
 19 13-14 p. 1701-1709
9 p.
 article
15 Immunization-related products: introduction to the panel discussion Milstien, Julie B.
 2001
 19 13-14 p. 1592-1593
2 p.
 article
16 Immunization with plasmid DNA expressing the caprine arthritis–encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein Beyer, J.C
 2001
 19 13-14 p. 1643-1651
9 p.
 article
17 Immunological analyses of human papillomavirus capsids Giroglou, Tzenan
 2001
 19 13-14 p. 1783-1793
11 p.
 article
18 Key drivers behind the development of global vaccine market Gréco, Michel
 2001
 19 13-14 p. 1606-1610
5 p.
 article
19 Licensing IP to ensure accessibility to vaccines and other immunisation-related products Mehta, J.M.
 2001
 19 13-14 p. 1581-1587
7 p.
 article
20 Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype Nöjd, Johan
 2001
 19 13-14 p. 1727-1731
5 p.
 article
21 Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA Orr, Nadav
 2001
 19 13-14 p. 1694-1700
7 p.
 article
22 Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid Eastcott, Jean W
 2001
 19 13-14 p. 1636-1642
7 p.
 article
23 Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice Fló, Juan
 2001
 19 13-14 p. 1772-1782
11 p.
 article
24 Prevention of vertical transmission of Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying NcSRS2 gene Nishikawa, Yoshifumi
 2001
 19 13-14 p. 1710-1716
7 p.
 article
25 Product development plan for new vaccine technologies Ellis, Ronald W
 2001
 19 13-14 p. 1559-1566
8 p.
 article
26 Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine Harrison, Christopher J
 2001
 19 13-14 p. 1820-1826
7 p.
 article
27 Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques Rosenwirth, Brigitte
 2001
 19 13-14 p. 1661-1670
10 p.
 article
28 Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans Treanor, John J.
 2001
 19 13-14 p. 1732-1737
6 p.
 article
29 Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting Yao, Zhi-Qiang
 2001
 19 13-14 p. 1628-1635
8 p.
 article
30 Th1 genetic adjuvants modulate immune responses in neonates Pertmer, Tamera M.
 2001
 19 13-14 p. 1764-1771
8 p.
 article
31 Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains Goldstein, Gideon
 2001
 19 13-14 p. 1738-1746
9 p.
 article
32 Use of live bacterial vaccine vectors for antigen delivery: potential and limitations Medina, Eva
 2001
 19 13-14 p. 1573-1580
8 p.
 article
33 Vaccines for the developing world: current status and future directions Wenger, Jay
 2001
 19 13-14 p. 1588-1591
4 p.
 article
34 WHO expectation and industry goals Vandersmissen, Walter
 2001
 19 13-14 p. 1611-1615
5 p.
 article
                             34 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands